QuantLogix ← ABBV scorecard
📅 ABBV Earnings Preview
ABBVIE INC.
Next report (est.)
11/23/2026
Countdown
71 days
EPS growth YoY
+290.4%
Revenue growth YoY
+10.2%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
08/03/2026 ±3.2% -2.3% over-priced
05/08/2026 ±2.1% -0.6% over-priced
11/04/2025 ±3.0% +1.9% over-priced
08/04/2025 ±3.3% +1.0% over-priced
05/09/2025 ±3.2% -0.5% over-priced
11/04/2024 ±2.7% -1.5% over-priced
08/07/2024 ±3.0% +1.0% over-priced
05/03/2024 ±2.9% +1.9% over-priced
Across these reports, options implied an average ±2.9% move vs an actual average of 1.3% — the stock stayed inside the implied band 100% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $2.03 $17.0B $3.6B
Q1 FY2026 $0.39 $15.0B $697M
Q4 FY2025 $1.02 $16.6B $1.8B
Q3 FY2025 $0.10 $15.8B $188M
Analyst posture
Buy / Strong Buy
32
Hold
7
Sell
0
Stable: +2 net change 30d
Live 5-factor engine read: Buy · 81/100 Full scorecard →
Get alerted before every ABBV report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on ABBV before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

ABBVIE INC. (ABBV) reports in 71 days, with the next report estimated for 11/23/2026. Across the last 8 reports, options priced an average ±2.9% earnings move while the stock actually moved 1.3% on average — the market has systematically over-priced ABBV's earnings risk. Fundamentals into the print: EPS up 290.4% year-over-year, revenue up 10.2%. QuantLogix's live 5-factor engine currently reads ABBV as a buy at 81/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →